Science Virometix AG Secures $15 Million for Pneumococcal Vaccine Development Virometix AG, a biotechnology company based in Schlieren, Switzerland, has successfully completed a financing round, securing $15 million from its existing shareholders. This funding... Editorial5 hours ago